Thank you for your support at this particularly challenging time.

As we start to see social distancing restrictions relax, we would like to take a moment to reflect on the past three months.

Perth Blood Institute (PBI) is proud of our resilience during this tough time and ever-changing climate. As an organisation we have managed to continue with our mission of improving the lives of people living with blood disorders.

The current pandemic highlights the necessity for clinical research and trials across all fields of medicine, and the key role Australia plays internationally.

Our Clinical Trials Team has remained busy, with 21 active clinical trials in motion. These include the world-first participant in a new trial – a novel therapy for treating lymphoproliferative disorders and lymphoma.

“This is an exciting opportunity for PBI to be a part of. This study will present us with world-first results which will impact those diagnosed with lymphoma.” Dr Maan Alwan, PBI Clinical Lead

Your ongoing support will help us to continue to offer Western Australians the opportunity to participate in new Clinical Trials as Australia becomes a global hub for both blood disorder and malignancy trials.

We understand this has been a particularly unsettling time for many patients. We have all of you front of mind and recognise how important it is to protect our community.

During this time, we have shared international research on our website to provide our supporters with clarity around the consequences of COVID-19 for patients with blood disorders.

Thrombosis has been in the spotlight with concerns for COVID-19 patients and the sedentary lifestyle many of us have been leading. We have launched a hub on our website with tools for patients and families – head to the support and resources tab for more information.

PBI recently featured in The West Australian’s guide to Wills and Bequests (published on Monday 25 May). This is one way you can contribute to the future of our research. We ask you to please consider the Perth Blood Institute when you next revise your will.

While we continue to maintain a positive outlook, we need your support more than ever. Your End of Financial Year gift will allow our scientists to continue to develop world-class research into blood disorders and enable our clinical trials unit to continue to grow.

Professor Ross Baker

Chair, Perth Blood Institute